▲ +34.59% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for MultiPlan in the last 3 months. The average price target is $10.00, with a high forecast of $10.00 and a low forecast of $10.00. The average price target represents a 34.59% upside from the last price of $7.43.
The current consensus among 2 contributing investment analysts is to buy stock in MultiPlan.
MultiPlan Corporation provides data analytics and technology-enabled cost management solutions to the U.S. healthcare industry. The company offers analytics-based services, which reduce medical costs for consumers and payors through data-driven algorithms that detect claims anomalies; network-based services that reduce medical costs through contracted discounts with healthcare providers and include independent preferred provider organizations in the United States; and payment integrity services, which reduce medical costs by identifying and removing improper and unnecessary charges before claims are paid. Its customers include national insurance companies, Blue Cross and Blue Shield plans, provider-sponsored health plans, third party administrators, bill review companies, Taft-Hartley plans, and other entities that pay medical bills in the commercial healthcare, government, workers' compensation, auto medical, and dental markets. The company was founded in 1980 and is headquartered in New York, New York.